LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Celastrol | 3.33 | uM | LJP6 | 3 | G08 | 72 | hr | 1401 | 1137 | 4223 | 0.2692 | -0.0938 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP5 | 1 | F02 | 72 | hr | 1401 | 975 | 4223 | 0.2309 | -0.1512 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP5 | 2 | F02 | 72 | hr | 1401 | 1186 | 4223 | 0.2808 | -0.0764 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP5 | 3 | F02 | 72 | hr | 1401 | 1099 | 4223 | 0.2602 | -0.1072 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP6 | 1 | G02 | 72 | hr | 1401 | 768 | 4223 | 0.1819 | -0.2245 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP6 | 2 | G02 | 72 | hr | 1401 | 852 | 4223 | 0.2018 | -0.1948 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP6 | 3 | G02 | 72 | hr | 1401 | 808 | 4223 | 0.1913 | -0.2104 |
| SK-BR-3 | CHIR-99021 | 3.33 | uM | LJP6 | 1 | P14 | 72 | hr | 1401 | 4196 | 4223 | 0.9936 | 0.9904 |
| SK-BR-3 | CHIR-99021 | 3.33 | uM | LJP6 | 2 | P14 | 72 | hr | 1401 | 4071 | 4223 | 0.9640 | 0.9461 |
| SK-BR-3 | CHIR-99021 | 3.33 | uM | LJP6 | 3 | P14 | 72 | hr | 1401 | 3735 | 4223 | 0.8844 | 0.8270 |
| SK-BR-3 | CP724714 | 3.33 | uM | LJP5 | 1 | A08 | 72 | hr | 1401 | 1749 | 4223 | 0.4142 | 0.1232 |
| SK-BR-3 | CP724714 | 3.33 | uM | LJP5 | 2 | A08 | 72 | hr | 1401 | 1802 | 4223 | 0.4267 | 0.1419 |
| SK-BR-3 | CP724714 | 3.33 | uM | LJP5 | 3 | A08 | 72 | hr | 1401 | 2019 | 4223 | 0.4781 | 0.2188 |
| SK-BR-3 | CP466722 | 3.33 | uM | LJP5 | 1 | I08 | 72 | hr | 1401 | 3952 | 4223 | 0.9358 | 0.9039 |
| SK-BR-3 | CP466722 | 3.33 | uM | LJP5 | 2 | I08 | 72 | hr | 1401 | 3249 | 4223 | 0.7693 | 0.6548 |
| SK-BR-3 | CP466722 | 3.33 | uM | LJP5 | 3 | I08 | 72 | hr | 1401 | 3470 | 4223 | 0.8217 | 0.7331 |
| SK-BR-3 | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 1401 | 2233 | 4223 | 0.5288 | 0.2947 |
| SK-BR-3 | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 1401 | 2548 | 4223 | 0.6034 | 0.4063 |
| SK-BR-3 | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 1401 | 2513 | 4223 | 0.5951 | 0.3939 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 1 | P08 | 72 | hr | 1401 | 2574 | 4223 | 0.6095 | 0.4155 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 2 | P08 | 72 | hr | 1401 | 3044 | 4223 | 0.7208 | 0.5821 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 3 | P08 | 72 | hr | 1401 | 3035 | 4223 | 0.7187 | 0.5789 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 1401 | 2738 | 4223 | 0.6483 | 0.4737 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 1401 | 2836 | 4223 | 0.6716 | 0.5084 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1401 | 3484 | 4223 | 0.8250 | 0.7381 |